• 1
    Shukla G, Srivastava O, Katiyar B, Joshi V, Mohan P. Psychiatric manifestations in temporal lobe epilepsy: a controlled study. Br J Psychiatry 1979;135:4117.
  • 2
    Fiordelli E, Beghi E, Bogliun G, Crespi V. Epilepsy and psychiatric disturbance: a cross-sectional study. Br J Psychiatry 1993;163:44650.
  • 3
    Manchanda R, Schaefer B, McLachlan R, et al. Psychiatric disorders in candidates for epilepsy surgery. J Neurol Neurosurg Psychiatry 1996;61:829.
  • 4
    Koch-Weser M, Garron D, Gilley D, et al. Prevalence of psychologic disorders after surgical treatment of seizures. Arch Neurol 1988;45:130811.
  • 5
    Silberman E, Sussman N, Skillings G, Callanan M. Aura phenomena and psychopathology: a pilot investigation. Epilepsia 1994;35:7784.
  • 6
    Victoroff J. DSM-III-R psychiatric diagnoses in candidates for epilepsy surgery: lifetime prevalence. Neuropsychiatry Neuropsychol Behav Neurol 1994;7:8797.
  • 7
    Altshuler L, Rausch R, Delrahim S, Kay J, Crandall P. Temporal lobe epilepsy, temporal lobectomy, and major depression. J Neuropsychiatry Clin Neurosci 11:43643.
  • 8
    Hermann B, Bell B, Seidenberg M, unpublished observations.
  • 9
    Kessler L, Burns B, Shapiro S, et al. Psychiatric diagnosis of medical service users: evidence from the Epidemiologic Catchment Area program. Am J Pub Health 1987;77:1824.
  • 10
    Hoeper E, Nycz G, Cleary P, Regier D, Goldberg I. Estimated prevalence of RDC mental disorder in primary medical care. Int J Ment Health 1979;8:615.
  • 11
    Bromfield EB, Altshuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol 1992;49:61723.
  • 12
    Wiegartz P, Seidenberg M, Woodard A, Gidal B, Hermann B. Comorbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 1999;53:325.
  • 13
    Regier D, Myers J, Kramer M, et al. The NIMH Epidemiologic Catchment Area program. Arch Gen Psychiatry 1984;41:93452.
  • 14
    Regier D, Narrow W, Rae D, Manderscheid R, Locke B, Goodwin F. The de facto US mental and addictive disorders service system. Arch Gen Psychiatry 1993;50:8594.
  • 15
    Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:819.
  • 16
    Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 1994.
  • 17
    Robertson M. Mood disorders associated with epilepsy. In: McConnellH, SnyderP, eds. Psychiatric comorbidity in epilepsy. Washington : American Psychiatric Press, Inc., 1998:13367.
  • 18
    Blumer D, Altshuler L. Affective disorders. In: EngelJ, PedleyT, eds. Epilepsy: a comprehensive textbook. Philadelphia : Lippincott-Raven, 1997:208399.
  • 19
    Blumer D, Montouris G, Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J Neuropsychiatry Clin Neurosci 1995;7:44556.
  • 20
    Lambert M, Robertson M. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40:2147.
  • 21
    Altshuler L. Depression and epilepsy. In: DevinskyO, TheodoreW, eds. Epilepsy and behavior. New York : John Wiley & Sons, 1991:4765.
  • 22
    Kanner A, Nieto J. Depressive disorders in epilepsy. Neurology 1999;53:2632.
  • 23
    Katon W, Von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:6776.
  • 24
    Spitzer R, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders: results from the Prime-MD 1000 study. JAMA 1995;274:15117.
  • 25
    McQuaid J, Stein M, Laffaye C, McCahill M. Depression in a primary care clinic: the prevalence and impact of an unrecognized disorder. J Affect Disord 1999;55:110.
  • 26
    Hirschfeld R, Keller M, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277:33340.
  • 27
    Ettinger A, Weisbrot DM, Nolan EE, et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998;39:5959.
  • 28
    O'Donoghue M, Goodridge D, Redhead K, Sander L, Duncan J. Assessing the psychosocial consequences of epilepsy: a community based study. Br J Gen Pract 1999;49:2114.
  • 29
    Hays R, Wells K, Sherbourne C, Spritzer K, Rogers W. Functioning and well-being outcomes of patients with depression compared with chronic general medical illness. Arch Gen Psychiatry 1995;52:119.
  • 30
    Wells K, Stewart A, Hays R, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989;262:9149.
  • 31
    Von Korff M, Ormel J, Katon W, Lin E. Disability and depression among high utilizers of health care. Arch Gen Psychiatry 1992;49:91100.
  • 32
    Simon G, Ormel J, Von Korff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995;152:3527.
  • 33
    Simon G, Von Korff M, Barlow W. Healthcare costs of primary care patients with recognized depression. Arch Gen Psychiatry 1995;52:8506.
  • 34
    Henk H, Katzelnick D, Kobak K, Greist J. Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization. Arch Gen Psychiatry 1996;53:899904.
  • 35
    Ormel J, Von Korff M, Van Brink W, Katon W, Brilman E, Oldehinkel T. Depression, anxiety, and social disability show synchrony of change in primary care patients. Am J Public Health 1993;83:38590.
  • 36
    Williams J, Kerber C, Mulrow C, Medina A, Aguilar C. Depressive disorders in primary care: prevalence, functional disability, and identification. J Gen Intern Med 1995;10:712.
  • 37
    Broadhead W, Blazer D, George L, Tse C. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990;264:25248.
  • 38
    Lehrner J, Kalchmayr R, Serles W, et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999;8:8892.
  • 39
    Hermann B, unpublished data.
  • 40
    Kendler K, Karkowski L, Prescott C. Casual relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999;156:83741.
  • 41
    Roth D, Goode KT, Williams VL, Faught E. Physical exercise, stressful life experience, and depression in adults with epilepsy. Epilepsia 1994;35:124855.
  • 42
    Bench C, Frackowiak R, Dolan R. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995;25:24751.
  • 43
    Bench C, Friston K, Brown R, Scott L, Frackowiak R, Dolan R. The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992;22:60715.
  • 44
    Bench C, Friston K, Brown R, Frackowiak R, Dolan R. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993;23:57990.
  • 45
    Biver F, Goldman S, Delvenne V, et al. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994;36:3818.
  • 46
    Bremner J, Innis R, Salomon R, et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 1997;54:36474.
  • 47
    Coffey C, Wilkinson W, Weiner R, et al. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993;50:716.
  • 48
    Drevets W, Price J, Simpson J, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:8247.
  • 49
    Drevets W, Videen T, Price J, Preskorn S, Casrmichael S, Raichle M. A functional anatomical study of unipolar depression. J Neurosci 1992;12:362841.
  • 50
    Duman R, Charney D. Cell atrophy and loss in major depression. Biol Psychiatry 1999;45:10834.
  • 51
    Mayberg H, Liotti M, Brannan S, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999;156:67582.
  • 52
    Rajkowska G, Miguel-Hidalgo J, Wei J, et al. Morphometric evidence for neuronal glial prefrontal cell pathology in major depression. Biol Psychiatry 1999;45:108598.
  • 53
    Teneback C, Nahas Z, Speer A, et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 1999;11:42635.
  • 54
    Triggs W, McCoy K, Greer R, et al. Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biol Psychiatry 1999;45:14406.
  • 55
    Schmitz EB, Moriarty J, Costa DC, Ring HA, Ell PJ, Trimble MM. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy. J Neurol Neurosurg Psychiatry 1997;62:45863.
  • 56
    Hermann BP, Seidenberg M, Haltiner A, Wyler AR. Mood state in unilateral temporal lobe epilepsy. Biol Psychiatry 1991;30:120518.
  • 57
    Seidenberg M, Hermann BP, Haltiner A, Noe A, Wyler AR. Depression in temporal lobe epilepsy: interaction between laterality of lesion and Wisconsin Card Sort performance. Neuropsychiatry Neuropsychol Behav Neurol 1995;8:817.
  • 58
    Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines impact on depression in primary care. JAMA 1995;273:102631.
  • 59
    Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996;53:92432.
  • 60
    Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression a randomized trial. Arch Gen Psychiatry 1999;56:110915.
  • 61
    Von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med 1998;60:1439.
  • 62
    Curran S, de Pauw K. Selecting an antidepressant for use in a patient with epilepsy. Drug Saf 1998;18:12533.
  • 63
    Schmitz B. Psychiatric syndromes related to antiepileptic drugs. Epilepsia 1999;40:6570.
  • 64
    Trimble M. Anticonvulsant-induced psychiatric disorders the role of forced normalisation. Drug Saf 1996;15:15966.
  • 65
    Monaco F, Cicolin A. Interactions between anticonvulsant and psychoactive drugs. Epilepsia 1999;40:716.
  • 66
    Pisani F, Spina E, Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 1999;40:4856.
  • 67
    Krishnamoorthy E, Trimble M. Forced normalization: clinical and therapeutic relevance. Epilepsia 1999;40:5764.
  • 68
    Depression in primary care: treatment of major depression, volume 2. Rockville, Maryland: Agency for Health Care Research and Policy, 1993: AHCRP publication 930511.
  • 69
    Greenfield S, Reizes J, Magruder K, Muenz L, Kopans B, Jacobs D. Effectiveness of community-based screening for depression. Am J Psychiatry 1997;154:13917.
  • 70
    Magruder K, Norquist G, Feil M, Kopans B, Jacobs D. Who comes to a voluntary depression screening program Am J Psychiatry 1995;152:161522.
  • 71
    Paykel E, Tylee A, Wright A, Priest R, Rix S, Hart D. The defeat depression campaign: psychiatry in the public arena. Am J Psychiatry 1997;154:5965.
  • 72
    Regier D, Hirschfeld R, Goodwin F, Burke J, Lazar J, Judd L. The NIMH depression awareness, recognition, and treatment program: structure aims and scientific basis. Am J Psychiatry 1988;145:13517.
  • 73
    Mental Health: A Report of the Surgeon General, Rockville , Md : US Dept of Health and Human Services; 2000.